Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin sensitisation: Key study: Based on the read-across approach from experimental data on analogue butan-2-one O,O',O''-(methylsilanetriyl)oxime (guinea-pig maximisation test, GLP study), the substance butan-2-one O,O',O''-(vinylsilanetriyl)oxime was determined to be skin sensitiser.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Justification for type of information:
REPORTING FORMAT FOR THE ANALOGUE APPROACH
The analogue Butan-2-one O,O',O''-(methylsilanetriyl)oxime which shares the same functional group with Butan-2-one O,O',O''-(vinylsilanetriyl)oxime, also has comparable values for the relevant molecular properties for skin sensitization.
See attached the reporting format.
Reason / purpose for cross-reference:
read-across source
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% (analogue substance)
No. with + reactions:
14
Total no. in group:
14
Remarks on result:
other: Read across from an analogue substance
Key result
Reading:
2nd reading
Hours after challenge:
28
Group:
test chemical
Dose level:
50% (analogue substance)
No. with + reactions:
14
Total no. in group:
15
Remarks on result:
other: Read across from an analogue substance
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50% (analogue substance)
No. with + reactions:
1
Total no. in group:
3
Remarks on result:
other: Read across from an analogue substance
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
50% (analogue substance)
No. with + reactions:
0
Total no. in group:
3
Remarks on result:
other: Read across from an analogue substance
Reading:
other: No details given
Group:
positive control
Remarks on result:
other: No details given
Interpretation of results:
other: Sensitising (according to CLP regulation)
Conclusions:
Based on the read-across approach from experimental results on analogue butan-2-one O,O',O''-(methylsilylidyne)trioxime, the read-across approach was applied and the substance butan-2-one O,O',O''-(vinylsilylidyne)trioxime was determined to be skin sensitiser.
Executive summary:

A guinea-pig maximisation test was conducted according to OECD 406 and GLP on the analogue substance butan-2-one O,O',O''-(methylsilylidyne)trioxime. 15 female guinea pigs were exposed to induction doses of 5% (intradermal) and 25% (epicutaneous) and a challenge dose of 50% test item. Another 3 females were used as negative controls. The results on the analogue reported a response to challenge in 14 of 15 animals at 24 and 48 h. Responses in 1 of 3 and 0 of 3 were reported at 24 and 48 hours, respectively, in the small negative control group. Based on these results, the read-across approach was applied and the substance butan-2-one O,O',O''-(vinylsilylidyne)trioxime was determined to be skin sensitiser since a response of 30% or more in an adjuvant test indicates sensitisation.

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
27 Aug 1985 - 20 Nov 1985
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
The study was conducted according to a test protocol that is comparable to the appropriate OECD guideline, with acceptable restrictions. The restrictions were the use of less animals than specified in the OECD test guideline.
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
adopted 1992
Deviations:
yes
Remarks:
Only 3 animals in the control group and 15 animals in the test group.
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
An appropriate guinea pig maximisation test is available which would not justify conducting an additional LLNA due to animal welfare.
Species:
guinea pig
Strain:
Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Hazelton Labs, Denver, PA, USA
- Age at study initiation: 5-6 weeks
- Housing: up to 3 per cage
- Diet: standard diet ad libitum
- Water: drinking water ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C):22±4
- Humidity (%): 50±15
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 1985-08-27 To: 1985-09-26
Route:
intradermal and epicutaneous
Vehicle:
propylene glycol
Concentration / amount:
Intradermal 5%; epicutaneous 25%
Route:
epicutaneous, semiocclusive
Vehicle:
propylene glycol
Concentration / amount:
50%
No. of animals per dose:
test: 15
negative control: 3 at challenge
Details on study design:
RANGE FINDING TESTS: said to have been conducted if necessary, but no details given in the report reviewed. The study schedule does not include a pretest, so it was probably not done.

A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections; 0.1 ml):
Injection 1: 5% test article in propylene glycol
Injection 2: FCA alone
Injection 3: 5% test article in FCA
Epicutaneous: 0.3 ml: 25% TS in propylene glycol
- Control groups:
Intradermal (3 pairs of injections; 0.1 ml):
Injection 1: vehicle
Injection 2: FCA alone
Injection 3: vehicle in FCA
Epicutaneous: 0.3 ml propylene glycol
- Site: two rows of 3 sites, one row either side of dorsal mid-line
- Frequency of applications: intradermal treatment day 0; topical induction day 7
- Duration: induction period continues to day 21
- Concentrations: intradermal 5%, epicutaneous 25%


B. CHALLENGE EXPOSURE
- No. of exposures: 1 (at two sites: TS and vehicle)
- Day of challenge: day 22
- Exposure period: 24h
- Test groups: 0.2 ml: 50% TS in propylene glycol
- Control groups: 0.2 ml: 50% TS in propylene glycol
- Site: flanks
- Concentrations: 50%


Challenge controls:
Negative: 6 animals were used at the induction stages. Only 3 were challenged with 50% TS. 3 animals were retained for a possible rechallenge.
Positive: dinitrochlorobenzene; no details are given
Positive control substance(s):
yes
Remarks:
dinitrochlorobenzene
Positive control results:
Dinitrochlorobenzene apparently yielded 100% response; no details are given.
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50%
No. with + reactions:
14
Total no. in group:
15
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50%
No. with + reactions:
14
Total no. in group:
15
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50%
No. with + reactions:
1
Total no. in group:
3
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
50%
No. with + reactions:
0
Total no. in group:
3
Reading:
other: No details given
Group:
positive control
Remarks on result:
other: No details given

Table 1: Incidence of dermal response to challenge dosing.

GROUP

MATERIAL

INTERVAL

DERMAL SCORES

SENSITIZATION INCIDENCE

 

 

 

0

1

2

3

 

Test

TS 50%

24h

1/15

1/15

4/15

9/15

14/15

 

48h*

1/15

2/15

4/15

8/15

14/15

 

Vehicle (propylene glycol)

24h

0/15

0/15

0/15

0/15

0/15

 

48h

0/15

0/15

0/15

0/15

0/15

Vehicle control

TS 50%

24h**

2/3

1/3

0/3

0/3

1/3

 

48h

3/3

0/3

0/3

0/3

0/3

 

Vehicle (propylene glycol)

0/3

0/3

0/3

0/3

0/3

0/3

 

0/3

0/3

0/3

0/3

0/3

0/3

Positive control

Dinitrochlorobenzene (no details given)

 

 

 

 

 

100% no details given

Skin reactions were graded:

0 no reaction

1 scattered mild redness

2 moderate and diffuse redness

3 intense redness and swelling

* 5 animals had eschar and 2 had necrosis

**1 animal had eschar

Interpretation of results:
other: Sensitising (according to CLP regulation)
Conclusions:
A guinea-pig maximisation test conducted with GLP but limited in some respects reported a response to challenge (using 50% test substance) in 14 of 15 animals at 24 and 48 h. Responses in 1 of 3 and 0 of 3 were reported at 24 and 48 hours, respectively, in the small negative control group. A response of 30% or more in an adjuvant test indicates sensitisation.
Executive summary:

A guinea-pig maximisation test conducted with GLP but limited in some respects reported a response to challenge (using 50% test substance) in 14 of 15 animals at 24 and 48 h. Responses in 1 of 3 and 0 of 3 were reported at 24 and 48 hours, respectively, in the small negative control group. A response of 30% or more in an adjuvant test indicates sensitisation.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

Skin sensitisation: Read-across approach from analogue substance butan-2-one O,O',O''-(methylsilanetriyl)oxime

Key study: A guinea-pig maximisation test was conducted with GLP was performed on analogue substance butan-2-one O,O',O''-(methylsilanetriyl)oxime. The results reported a response to challenge (using 50% test substance) in 14 of 15 animals at 24 and 48 h. Responses in 1 of 3 and 0 of 3 were reported at 24 and 48 hours, respectively, in the small negative control group. A response of 30% or more in an adjuvant test indicates sensitisation. Based on this experimental data, a read-across approach was applied and the substance butan-2-one O,O',O''-(vinylsilanetriyl)oxime was determined to be skin sensitiser.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the available information, the test substance butan-2-one O,O',O''-(vinylsilanetriyl)oxime is classified as Sensitiser Category 1 according to CLP Regulation (EC) No 1272/2008 (>30 responding at >1% intradermal induction dose).